Arch Therapeutics Inc (ARTH)

[formerdtrader]

Interesting thing.. the 2nd annual Source Capital Group Disruptive Biotech conference in NYC in February invites about 50 cutting edge companies traded on the NYSE or NASDAQ that have products that will revolutionize the biotech industry.

I have been looking into the participants that were invited and almost all of them are NYSE or NASDAQ listed stocks (not OTC). Arch is one of the only that is on the lesser exchange.

Obviously Source Capital sees them as a potential major player!!!